2-(5-(tert-Butyl)-2-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Catalog No.: 
ACTKDG240
CAS No.: 
2819649-88-0
Molecular Formula: 
C16H24BFO2
Molecular Weight: 
278.18
2-(5-(tert-Butyl)-2-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$331.00In stockInquiry
250mg95%$541.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(5-(tert-Butyl)-2-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
IUPAC Name2-(5-(tert-butyl)-2-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Molecular FormulaC16H24BFO2
Molecular Weight278.18
SMILESCC1(C(C)(OB(O1)C2=CC(C(C)(C)C)=CC=C2F)C)C
InChI KeyAJVNHVNFWMWYQE-UHFFFAOYSA-N
Synonym1,3,2-Dioxaborolane, 2-[5-(1,1-dimethylethyl)-2-fluorophenyl]-4,4,5,5-tetramethyl-
CAS No.2819649-88-0

Synthetic Route by SureRoute

1. ACTKDG240 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMEPX458 route compound structure diagram
    ACMEPX45834252-94-3In Stock
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3In Stock
  4. Then
  5. ACTKDG240 route product structure diagram
    ACTKDG2402819649-88-0In Stock
Inquiry

2. ACTKDG240 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3In Stock
  4. Then
  5. ACTKDG240 route product structure diagram
    ACTKDG2402819649-88-0In Stock
Inquiry

3. ACTKDG240 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3In Stock
  4. Then
  5. ACTKDG240 route product structure diagram
    ACTKDG2402819649-88-0In Stock
Inquiry

Comments (0)